Chong Kun Dang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Chong Kun Dang Pharmaceutical has a total shareholder equity of ₩826.5B and total debt of ₩209.5B, which brings its debt-to-equity ratio to 25.4%. Its total assets and total liabilities are ₩1,414.8B and ₩588.3B respectively. Chong Kun Dang Pharmaceutical's EBIT is ₩245.9B making its interest coverage ratio 373.5. It has cash and short-term investments of ₩393.3B.
Key information
25.4%
Debt to equity ratio
₩209.52b
Debt
| Interest coverage ratio | 373.5x |
| Cash | ₩393.30b |
| Equity | ₩826.49b |
| Total liabilities | ₩588.33b |
| Total assets | ₩1.41t |
Recent financial health updates
Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly
May 27
Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?
Apr 19Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?
Jan 12Recent updates
Investors Don't See Light At End Of Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Tunnel
Jun 12Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly
May 27A Look At The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
Apr 09Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?
Apr 19Here's Why I Think Chong Kun Dang Pharmaceutical (KRX:185750) Is An Interesting Stock
Apr 05Declining Stock and Solid Fundamentals: Is The Market Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750)?
Mar 09Estimating The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
Feb 24The Chong Kun Dang Pharmaceutical (KRX:185750) Share Price Is Up 112% And Shareholders Are Boasting About It
Feb 11Is Chong Kun Dang Pharmaceutical Corp. (KRX:185750) An Attractive Dividend Stock?
Jan 27
Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?
Jan 12With EPS Growth And More, Chong Kun Dang Pharmaceutical (KRX:185750) Is Interesting
Dec 28What Kind Of Shareholders Hold The Majority In Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Shares?
Dec 09Could The Market Be Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750) Given Its Attractive Financial Prospects?
Nov 24Financial Position Analysis
Short Term Liabilities: A185750's short term assets (₩956.4B) exceed its short term liabilities (₩502.4B).
Long Term Liabilities: A185750's short term assets (₩956.4B) exceed its long term liabilities (₩86.0B).
Debt to Equity History and Analysis
Debt Level: A185750 has more cash than its total debt.
Reducing Debt: A185750's debt to equity ratio has increased from 24.5% to 25.4% over the past 5 years.
Debt Coverage: A185750's debt is well covered by operating cash flow (153.3%).
Interest Coverage: A185750's interest payments on its debt are well covered by EBIT (373.5x coverage).